Latest Deep Track Capital, LP Stock Portfolio

Deep Track Capital, LP Performance:

2025 Q4: 31.59%YTD: 52.17%2024: -1.46%

Performance for 2025 Q4 is 31.59%, and YTD is 52.17%, and 2024 is -1.46%.

About Deep Track Capital, LP and 13F Hedge Fund Stock Holdings

On 2026-02-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Deep Track Capital, LP reported an equity portfolio of $5.6 Billions as of 31 Dec, 2025.

The top stock holdings of Deep Track Capital, LP are IMVT, GH, . The fund has invested 5.2% of it's portfolio in IMMUNOVANT INC and 5.1% of portfolio in GUARDANT HEALTH INC .

The fund managers got completely rid off AKERO THERAPEUTICS INC (AKRO), 89BIO INC (ETNB) and PROTAGONIST THERAPEUTICS INC (PTGX) stocks. They significantly reduced their stock positions in TERNS PHARMACEUTICALS INC (TERN), RAPT THERAPEUTICS INC (RAPT) and XENON PHARMACEUTICALS INC (XENE). Deep Track Capital, LP opened new stock positions in VERA THERAPEUTICS INC (VERA), GRAIL INC and MOONLAKE IMMUNOTHERAPEUTICS (MLTX). The fund showed a lot of confidence in some stocks as they added substantially to BIOMARIN PHARMACEUTICAL INC (BMRN), CORMEDIX INC (CRMD) and X4 PHARMACEUTICALS INC (XFOR).

Deep Track Capital, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Deep Track Capital, LP made a return of 31.59% in the last quarter. In trailing 12 months, it's portfolio return was 52.17%.

Performance
S&P 500

New Buys

Ticker	$ Bought
vera therapeutics inc	142,862,000
grail inc	87,541,200
moonlake immunotherapeutics	60,760,700
alkermes plc	55,960,000
centessa pharmaceuticals plc	50,020,000
soleno therapeutics inc	46,300,000
verastem inc	44,319,400
enanta pharmaceuticals inc	30,859,800

New stocks bought by Deep Track Capital, LP

Additions

Ticker	% Inc.
biomarin pharmaceutical inc	9,153
cormedix inc	954
x4 pharmaceuticals inc	346
engene holdings inc	95.48
cybin inc	85.43
tango therapeutics inc	68.75
vaxcyte inc	33.33
dyne therapeutics inc	32.5

Additions to existing portfolio by Deep Track Capital, LP

Reductions

Ticker	% Reduced
terns pharmaceuticals inc	-89.74
rapt therapeutics inc	-85.3
xenon pharmaceuticals inc	-69.46
ionis pharmaceuticals inc	-55.36
viridian therapeutics inc	-53.07
guardant health inc	-32.6
bridgebio pharma inc	-32.49
ocular therapeutix inc	-32.36

Deep Track Capital, LP reduced stake in above stock

Sold off

Ticker	$ Sold
89bio inc	-137,536,000
akero therapeutics inc	-189,966,000
olema pharmaceuticals inc	-33,973,000
autolus therapeutics plc	-4,186,840
jade biosciences inc	-19,675,500
protagonist therapeutics inc	-113,973,000
gh research plc	-17,875,000
pepgen inc	-5,544,000

Deep Track Capital, LP got rid off the above stocks

Sector Distribution

Deep Track Capital, LP has about 77.8% of it's holdings in Healthcare sector.

Sector	%
Healthcare	77.8
Others	22.2

Market Cap. Distribution

Deep Track Capital, LP has about 14.1% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
MID-CAP	41.7
UNALLOCATED	22.2
SMALL-CAP	21.2
LARGE-CAP	14.1

Stocks belong to which Index?

About 59.6% of the stocks held by Deep Track Capital, LP either belong to S&P 500 or RUSSELL 2000 index.

Index	%
RUSSELL 2000	59.6
Others	40.4

Top 5 Winners (%)		%
TERN	terns pharmaceuticals inc	241.4 %
	structure therapeutics inc	146.6 %
NRIX	nurix therapeutics inc	91.3 %
	mbx biosciences inc	78.0 %
	maze therapeutics inc	56.5 %

Top 5 Winners ($)		$
	structure therapeutics inc	173.0 M
GH	guardant health inc	137.9 M
TERN	terns pharmaceuticals inc	135.9 M
IMVT	immunovant inc	98.8 M
DVAX	dynavax technologies corp	85.7 M

Top 5 Losers (%)		%
ANIP	ani pharmaceuticals inc	-13.5 %
ALGS	aligos therapeutics inc	-4.9 %
IMCR	immunocore hldgs plc	-4.2 %
GERN	geron corp	-3.3 %
	crescent biopharma inc.	-0.3 %

Top 5 Losers ($)		$
ANIP	ani pharmaceuticals inc	-5.9 M
IMCR	immunocore hldgs plc	-3.1 M
GERN	geron corp	-1.8 M
ALGS	aligos therapeutics inc	-0.2 M
	crescent biopharma inc.	0.0 M

Deep Track Capital, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Deep Track Capital, LP

Deep Track Capital, LP has 53 stocks in it's portfolio. About 41.5% of the portfolio is in top 10 stocks. ANIP proved to be the most loss making stock for the portfolio. was the most profitable stock for Deep Track Capital, LP last quarter.

Last Reported on: 13 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ACAD	acadia pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

AKRO	akero therapeutics inc	0.00	0.00	0.00	sold off	-100

ALGS	aligos therapeutics inc	0.07	444,110	4,139,100	unchanged	0.00

ALKS	alkermes plc	1.00	2,000,000	55,960,000	new

ANIP	ani pharmaceuticals inc	0.67	477,684	37,708,400	added	6.15

APLS	apellis pharmaceuticals inc	3.47	7,750,000	194,680,000	reduced	-3.13

ATAI	atai beckley nv	0.34	4,677,290	19,130,100	new

AUTL	autolus therapeutics plc	0.00	0.00	0.00	sold off	-100

AVTE	jade biosciences inc	0.00	0.00	0.00	sold off	-100

AVTX	avalo therapeutics inc	0.00	0.00	0.00	sold off	-100

AXSM	axsome therapeutics inc	3.74	1,150,000	210,036,000	added	27.78

BBIO	bridgebio pharma inc	1.10	810,142	61,967,800	reduced	-32.49

BMRN	biomarin pharmaceutical inc	2.44	2,300,000	136,689,000	added	9,153

CDTX	cidara therapeutics inc	0.00	0.00	0.00	sold off	-100

CLDX	celldex therapeutics inc new	0.92	1,900,740	51,624,000	reduced	-4.96

CMPS	compass pathways plc	0.90	7,334,320	50,606,800	reduced	-6.68

CNTA	centessa pharmaceuticals plc	0.89	2,000,000	50,020,000	new

CNTX	context therapeutics inc	0.19	7,419,360	10,906,500	unchanged	0.00

COGT	cogent biosciences inc	0.29	453,102	16,094,200	new

CRMD	cormedix inc	1.09	5,274,080	61,337,500	added	954